AKT1 and cancer: Similarly, the ablation of oncogenic drivers, such as KRASG12D or cMyc, produced compensatory autocrine upregulation of IGFR-AKT pathway that was interpreted as crucial for resistance of dormant cancer cells and recurrence39.